Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 50.65 |
| Open | 51.26 |
| Bid | 52.47 x 1800 |
| Ask | 52.48 x 2200 |
| Day's range | 51.13 - 52.70 |
| 52-week range | 38.48 - 61.71 |
| Volume | |
| Avg. volume | 28,091,438 |
| Market cap | 294.404B |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 12.03 |
| EPS (TTM) | 4.36 |
| Earnings date | 26 Jul 2022 - 01 Aug 2022 |
| Forward dividend & yield | 1.60 (3.16%) |
| Ex-dividend date | 12 May 2022 |
| 1y target est | 59.33 |
- Motley Fool
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding
Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.
- FX Empire
Best Healthcare Stocks To Buy In May
Pfizer and Merck managed to gain solid upside momentum despite broad market pullback.
- Zacks
Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide
FDA grants emergency approval to Pfizer's COVID-19 vaccine for use in children 5- to 11-year old and approves Lilly's (LLY) novel diabetes treatment, Mounjaro (tirzepatide).
© 2022 Yahoo. All rights reserved.
